News | December 05, 2021
Monthly production capacity of Covishield and Covaxin touches 90% : Govt
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
Serum has a capacity of 250-275 million whereas Bharat Biotech has a capacity of 50-60 million
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Share of government health expenditure in total health expenditure increases to 40.8% (2017-18) from 28.6% (2013-14)
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
The union health ministry notifies the protocol and this move will also help in organ donation
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
It is the world’s first DNA-based Covid vaccine
The export policy of all diagnostic kits and reagents (including instruments /apparatus) ... is being made free with immediate effect," the directorate general of foreign trade (DGFT) said in a notification
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
Subscribe To Our Newsletter & Stay Updated
